NANOG and esophageal cancer: One study 39 was excluded from the meta-analysis of NANOG and the sub-analysis showed no significant association between the expression of NANOG and the survival of patients affected by esophageal cancer (HR 1.72; 95%CI 0.87-3.40; I2 27%; p=0.12) (Figure 3C).